IP Library › Granted Patent US 12,421,410
Granted Patent B2
US 12,421,410 · App. 17/786,977 · Granted Sep 23, 2025

Active energy ray curable inkjet ink and active energy ray curable ink set

Inventor: Gosuke Kikutsuji (Tokyo, JP)
Assignees: artience Co., Ltd.; TOYOCOLOR CO., LTD.
C09D11/40C09D11/037C09D11/101C09D11/107C09D11/322C09D11/38B41M5/0023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,421,410
App. No.
17/786,977
Granted
Sep 23, 2025
Kind
B2
Abstract

An active energy ray curable inkjet ink comprising a pigment (A), a colorant derivative (B), a pigment dispersing resin (C) and a polymerizable compound (D), wherein the pigment (A) contains a C.I. pigment blue 15:6 and a quinacridone-based pigment at a specific amount and a specific ratio, the colorant derivative (B) contains a quinacridone-based pigment derivative, and the pigment dispersing resin (C) has an acid value and an amine value in a specific range.

Claims (11)

1. An active energy ray curable inkjet ink comprising a pigment (A), a colorant derivative (B), a pigment dispersing resin (C) and a polymerizable compound (D), wherein

the pigment (A) contains a C.I. pigment blue 15:6 and a quinacridone-based pigment,

the total mass of the blending amount of the C.I. pigment blue 15:6 and the blending amount of the quinacridone-based pigment is from 2 to 10% by mass based on the total mass of the ink,

the mass ratio of the C.I. pigment blue 15:6 and the quinacridone-based pigment is from 3:1 to 1:3,

the colorant derivative (B) contains a quinacridone-based pigment derivative, and

satisfying the relationship C1≥C2>0 when the acid value of the pigment dispersing resin (C) is denoted as C1 (mgKOH/g), and the amine value of the pigment dispersing resin (C) is denoted as C2 (mgKOH/g).

2. The active energy ray curable inkjet ink according to claim 1 , wherein the polymerizable compound (D) comprises from 20 to 60% by mass of 2-(2-vinyloxyethoxy) ethyl acrylate based on the total mass of the inkjet ink.

3. The active energy ray curable inkjet ink according to claim 1 further comprising a photopolymerization initiator (E), and comprising at least one type of α-hydroxyacetophenone photopolymerization initiator (E-1) as the photopolymerization initiator (E).

4. The active energy ray curable inkjet ink according to claim 1 further comprising a photopolymerization initiator (E), and comprising at least one type of α-hydroxyacetophenone photopolymerization initiator (E-1) as the photopolymerization initiator (E).

5. A printed matter obtained by printing the active energy ray curable inkjet ink according to claim 1 on a recording medium.

6. The printed matter obtained by printing the active energy ray curable ink set according to claim 4 on a recording medium.

Assignments (2)
CHANGE OF NAME Recorded Mar 7, 2024
From: TOYO INK SC HOLDINGS CO., LTD
To: ARTIENCE CO., LTD.
Reel/Frame 066763/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2022
From: KIKUTSUJI, GOSUKE
To: TOYO INK SC HOLDINGS CO., LTD.; TOYOCOLOR CO., LTD.
Reel/Frame 060321/0721 →
Priority Claims (1)
JP 2019-230092 · Dec 20, 2019 · national
Continuity (1)
Related Publication 20230102004A1 · Mar 30, 2023
References Cited (49)
US 5919299A · Kilmurray · 1999 [cited by examiner]
US 6918958B2 · Weber · 2005 [cited by examiner]
US 7211139B2 · Robertson · 2007 [cited by examiner]
US 7585364B2 · Deroover · 2009 [cited by examiner]
US 7648570B2 · Deroover · 2010 [cited by examiner]
US 7648572B2 · Deroover · 2010 [cited by examiner]
US 7699923B2 · Hoogmartens · 2010 [cited by examiner]
US 8022117B2 · Deroover · 2011 [cited by examiner]
US 8097663B2 · Bernaerts · 2012 [cited by examiner]
US 8197584B2 · Claes · 2012 [cited by examiner]
US 8828132B2 · Higashi · 2014 [cited by examiner]
US 11845874B2 · Retailleau · 2023 [cited by examiner]
US 20080295734A1 · Deroover · 2008 [cited by applicant]
US 20080314285A1 · Deroover · 2008 [cited by examiner]
US 20090092801A1 · Sato · 2009 [cited by examiner]
US 20100043670A1 · Shiono et al. · 2010 [cited by applicant]
US 20100221654A1 · Reichwagen · 2010 [cited by examiner]
US 20110132228A1 · Shiono et al. · 2011 [cited by applicant]
US 20120026226A1 · Kikuchi · 2012 [cited by applicant]
US 20130141504A1 · Saito et al. · 2013 [cited by applicant]
US 20190359836A1 · Yamaguchi et al. · 2019 [cited by applicant]
US 20210332255A1 · Courtet · 2021 [cited by examiner]
US 20220403198A1 · Retailleau · 2022 [cited by examiner]
US 20250034417A1 · Kawamoto · 2025 [cited by examiner]
CN 101316899A · 2008 [cited by applicant]
CN 101659807A · 2010 [cited by applicant]
CN 103131260A · 2013 [cited by applicant]
EP 3118271A1 · 2017 [cited by applicant]
JP 2005200560A · 2005 [cited by applicant]
JP 2009197173A · 2009 [cited by applicant]
JP 2009285904A · 2009 [cited by applicant]
JP 2010047723A · 2010 [cited by applicant]
JP 2011116876A · 2011 [cited by applicant]
JP 2012030399A · 2012 [cited by applicant]
JP 2015183147A · 2015 [cited by applicant]
JP 2017171789A · 2017 [cited by applicant]
JP 2017177353A · 2017 [cited by applicant]
WO WO0204563A1 · 2002 [cited by examiner]
WO WO2008095801A2 · 2008 [cited by examiner]
WO 2009010141A2 · 2009 [cited by applicant]
WO WO2009010140A2 · 2009 [cited by examiner]
WO 2015033841A1 · 2015 [cited by applicant]
WO 2018105355A1 · 2018 [cited by applicant]
WO 2018131400A1 · 2018 [cited by applicant]
WO WO2019081339A1 · 2019 [cited by examiner]
Chinese Office Action dated Nov. 28, 2022 in Chinese Application No. 202080088691.9. [cited by applicant]
International Search Report for PCT/JP2020/043031 dated Jan. 26, 2021 [PCT/ISA/210]. [cited by applicant]
Official Action issued on Jul. 7, 2020 in counterpart JP Application No. 2019-230092. [cited by applicant]
Extended European Search Report dated Jan. 5, 2023 in Application No. 20904126.8. [cited by applicant]